Refresh

Dr. Reddy's Laboratories Ltd.

Price on BSE   22 Jan,13:50 LIVE
1,217.05
+61.55
(+5.33%)

© 2026 Rediff.com
  • Volume :
  • 546,383.00
  • Prev Close :
  • 1,155.50
  • Day's H/L (Rs.) :
  • 1,225.00 - 1,188.95
  • 52wk H/L (Rs.) :
  • 1,377.95 - 1,025.90
  • Mkt Cap (Rs. Cr) :
  • 101,575.00
Price on NSE   22 Jan,13:53 LIVE
1,217.80
+60.60
(+5.24%)

© 2026 Rediff.com
  • Volume :
  • 4,910,205.00
  • Prev Close :
  • 1,157.20
  • Day's H/L (Rs.) :
  • 1,225.00 - 1,187.70
  • 52wk H/L (Rs.) :
  • 1,379.70 - 1,020.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com   29 min(s) ago
Domestic sales a booster dose for pharma revenues
Rediff.com   2 day(s) ago
Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud
Rediff.com   10 Nov 2025
'India Should Move Quickly As Conditions Change'
Rediff.com   02 Jan 2026
Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com   22 Dec 2025
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
18.01
EPS (Rs.)
64.14
Sales (Rs. Cr)
4,618.60
Face Value (Rs.)
1
Net Profit Margin(%)
23.14
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
18.53

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr
Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.
Jan 21, 2026 18:20
Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact
Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.
Dec 08, 2025 14:49
Dr Reddy''s Biosimilar Approved in Europe
Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.
Nov 24, 2025 17:22
Dr Reddy''s Srikakulam Unit Gets USFDA VAI
Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.
Oct 21, 2025 12:46
Glenmark, Dr Reddy''s Recall Products in US: USFDA
Glenmark and Dr Reddy''s recall products in the US due to manufacturing issues, says USFDA. Recalls include oral contraceptives and muscle relaxants.
Oct 19, 2025 10:20

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

Fujiyama Solar Plant in UP: Rs 300 Cr Investment
Fujiyama commissions a Rs 300 cr, 1 GW solar cell plant in UP to boost in-house capabilities and reduce import dependence. Details inside.
Jan 22, 2026 13:40
WEF Partners with Telangana for 'Rising 2047' Vision
World Economic Forum to partner with Telangana on its 'Rising 2047' vision. Focus on economic growth, EVs, and renewable energy.
Jan 22, 2026 13:28
South India Housing Sales Up 15% | PropTiger Report
Bengaluru, Hyderabad, Chennai housing sales increased 15% last year. PropTiger reports on property market trends in major Indian cities.
Jan 22, 2026 12:03
Optimist Raises $12M Seed Funding
Optimist, a cooling solutions startup, raises $12M led by Accel & Arkam. Plans to scale manufacturing, R&D, and market operations.
Jan 22, 2026 12:01
PhonePe IPO: Walmart, Tiger Global to Offload Stakes
Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.
Jan 22, 2026 11:44

More News »

Top News

Fujiyama Solar Plant in UP: Rs 300 Cr Investment
Fujiyama commissions a Rs 300 cr, 1 GW solar cell plant in UP to boost in-house capabilities and reduce import dependence. Details inside.
Jan 22, 2026 13:40
WEF Partners with Telangana for 'Rising 2047' Vision
World Economic Forum to partner with Telangana on its 'Rising 2047' vision. Focus on economic growth, EVs, and renewable energy.
Jan 22, 2026 13:28
Bank of India Shares Jump on Q3 Earnings
Bank of India shares surge after reporting a 7% rise in Q3 net profit. Reached a 52-week high. Market valuation increased significantly.
Jan 22, 2026 13:26
MP CM at Davos: Investment Buzz & Growth Policies
Madhya Pradesh CM Mohan Yadav highlights state policies attracting investment at Davos World Economic Forum. Focus on growth, reforms, and progress.
Jan 22, 2026 13:17
MP CM at Davos: Investment Buzz & Growth Story
Madhya Pradesh CM Mohan Yadav highlights state policies attracting investment at Davos. Showcasing growth, reforms, and economic progress.
Jan 22, 2026 13:13

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com